As of January 22, 2025, Skye Bioscience (SKYE) has a market cap of $78.576 million USD. According to our data, Skye Bioscience is ranked No.7871 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $78.58 M |
-8.48%
|
Dec 31, 2024 | $85.86 M |
4.04%
|
Dec 29, 2023 | $82.52 M |
-32.00%
|
Dec 30, 2022 | $0.12 B |
-69.23%
|
Dec 31, 2021 | $0.39 B |
30.00%
|
Dec 31, 2020 | $0.30 B |
-69.47%
|
Dec 31, 2019 | $0.99 B |
-67.25%
|
Dec 31, 2018 | $3.03 B |
163.16%
|
Dec 29, 2017 | $1.15 B |
-49.67%
|
Dec 30, 2016 | $2.29 B |
-56.86%
|
Dec 31, 2015 | $5.31 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Tilray
TLRY
|
$1.06 B |
0.000 M
|
Canada
|
Canopy Growth
CGC
|
$0.33 B |
58.562 M
|
Canada
|
Aurora Cannabis
ACB
|
$0.21 B |
-0.000 M
|
Canada
|
Cronos Group
CRON
|
$0.73 B |
0.000 M
|
Canada
|
Curaleaf
CURLF
|
$1.04 B |
0.130 B
|
USA
|
OrganiGram Holdings
OGI
|
$0.20 B |
0.631 M
|
Canada
|
Market Cap | = | SKYE Stock Price | * | SKYE Shares Outstanding |
= | $2.59 | * | 30.34 M | |
= | $78.58 M |